Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1989;14:488-497

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, P. C.
Right arrow Articles by Timmermans, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, P. C.
Right arrow Articles by Timmermans, P. B.

Hypertension, Vol 14, 488-497, Copyright © 1989 by American Heart Association


ARTICLES

Effect of a monoclonal antibody to angiotensin II on hemodynamic responses to noradrenergic stimulation in pithed rats

PC Wong, TM Reilly and PB Timmermans
Medical Products Department, E.I. du Pont de Nemours & Company, Inc., Wilmington, DE 19880-0400.

A specific angiotensin II monoclonal antibody, KAA8, was used to examine the interaction between sympathetic function and angiotensin II in pithed rats. KAA8, at 5 or 50 mg/kg i.v., did not alter the mean blood pressure, cardiac output, total peripheral resistance, or heart rate responses to sympathetic neural stimulation (0.25-4.0 Hz) or to norepinephrine (0.3-3 micrograms/kg i.v.) but blocked significantly the hemodynamic responses to angiotensin II (0.03-1.0 microgram/kg i.v.) and to angiotensin III (0.3-10 micrograms/kg i.v.). KAA8 treatment also reduced the plasma immunoreactive angiotensin II from 2,880 +/- 475 pg/ml to an undetectable level. In contrast, captopril (5 mg/kg i.v.) and saralasin (10 or 50 micrograms/kg/min i.v.) inhibited the mean blood pressure and total peripheral resistance responses, but not the cardiac output and heart rate responses, to sympathetic neural stimulation and to norepinephrine. These results, which confirm previous findings by Kaufman and Vollmer (Kaufman LJ, Vollmer RR: Endogenous angiotensin II facilitates sympathetically mediated hemodynamic responses in pithed rats. J Pharmacol Exp Ther 1985;235:128- 134), demonstrate that angiotensin II selectively potentiates the sympathetic vascular function in the pithed rat. However, our results suggest that circulating angiotensin II does not appear to interact with the sympathetic vascular function. It is speculated that in the pithed rat the sympathetic vascular response is enhanced by vascular- formed angiotensin II.


This article has been cited by other articles:


Home page
HypertensionHome page
M. Boddi, L. Poggesi, M. Coppo, N. Zarone, S. Sacchi, C. Tania, and G. G. N. Serneri
Human Vascular Renin-Angiotensin System and Its Functional Changes in Relation to Different Sodium Intakes
Hypertension, March 1, 1998; 31(3): 836 - 842.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Erdmann, K. Fuxe, and D. Ganten
Subcellular Localization of Angiotensin II Immunoreactivity in the Rat Cerebellar Cortex
Hypertension, November 1, 1996; 28(5): 818 - 824.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Moriguchi, E. A. Tallant, K. Matsumura, T. M. Reilly, H. Walton, D. Ganten, and C. M. Ferrario
Opposing Actions of Angiotensin-(1-7) and Angiotensin II in the Brain of Transgenic Hypertensive Rats
Hypertension, June 1, 1995; 25(6): 1260 - 1265.
[Abstract] [Full Text]